Development and Open Trial of a Psychosocial Intervention for Young Children With Chronic Tics: The CBIT-JR Study.


Journal

Behavior therapy
ISSN: 1878-1888
Titre abrégé: Behav Ther
Pays: England
ID NLM: 1251640

Informations de publication

Date de publication:
07 2020
Historique:
received: 06 05 2019
revised: 09 10 2019
accepted: 13 10 2019
entrez: 27 6 2020
pubmed: 27 6 2020
medline: 18 12 2020
Statut: ppublish

Résumé

The Comprehensive Behavioral Intervention for Tic Disorders (CBIT) has demonstrated efficacy in large randomized controlled trials for children (≥9 yrs), adolescents and adults with Tourette Syndrome and Chronic Tic Disorders. Given the early age of onset for tic disorders, a large portion of affected individuals with chronic tic disorders are less than 9 years of age and appropriate developmental adaptations of behavioral treatment have not yet been tested. The goal of this study was to adapt and evaluate the acceptability and utility of a family-based adaptation of CBIT for children under 9 years of age. Children 5-8 years of age (N = 15) with chronic tics were recruited from three study sites. CBIT was adapted for use with young children and included habit reversal strategies introduced in a developmentally appropriate game format and function-based interventions to reduce family accommodation of and attention to tic symptoms. Children and parents described high level of treatment satisfaction and study retention rate was 100%. Treatment response rate was 54% (CGI-I = 1 or 2) with a significant decrease in the YGTSS total score (Cohen's d = 0.73) that was largely maintained at 3-month and 1-year follow-up assessments. Treatment was associated with reduction of some symptoms of tic-related comorbid syndromes and with changes in parental accommodation and attention to tics. Future research should determine if parental attention to tics and symptom accommodation are important mediators of treatment outcome, or if participating in this intervention at a younger age may prevent the chronic course of tic symptoms.

Identifiants

pubmed: 32586437
pii: S0005-7894(19)30126-1
doi: 10.1016/j.beth.2019.10.004
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

659-669

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Shannon M Bennett (SM)

Weill Cornell Medical College. Electronic address: smb9017@med.cornell.edu.

Matthew Capriotti (M)

San Jose State University; University of California San Francisco.

Christopher Bauer (C)

Marquette University.

Susanna Chang (S)

UCLA Semel Institute for Neuroscience and Human Behavior.

Alex E Keller (AE)

Boston University.

John Walkup (J)

Lurie Children's Hospital.

Douglas Woods (D)

Marquette University.

John Piacentini (J)

UCLA Semel Institute for Neuroscience and Human Behavior.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH